North American Fetal Therapy Network Biannual Scientific Meetings

北美胎儿治疗网络每两年一次的科学会议

• 批准号: 7800324
• 负责人: Anthony Johnson
• 金额: $ 0.6万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-06 至 2014-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7800324
• 关键词: Academic Medical Centers; Address; American; Area; Biometry; Canada; Clinical; Clinical Research; Collaborations; Development; Disabled Persons; Educational workshop; Ethical Issues; European; Fetal Diseases; Fetal Therapies; Financial Support; Funding; Future; Individual; Industry; Medical Ethics; Mentors; Minority Groups; Mission; National Heart, Lung, and Blood Institute; National Institute of Child Health and Human Development; Natural History; Nature; Needs Assessment; North Carolina; Outcome; Participant; Pediatric Hospitals; Peer Review; Philadelphia; Process; Protocols documentation; Rare Diseases; Research; Research Personnel; Research Project Grants; Research Proposals; San Francisco; Therapeutic; Therapeutic Studies; United States; United States National Institutes of Health; Universities; Woman; authority; cost; fetal; fetal diagnosis; improved; innovation; meetings; member; organizational structure; prenatal intervention; prenatal therapy; public health relevance

DESCRIPTION (provided by applicant): Support is requested to underwrite the cost of the North American Fetal Therapy Network (NAFTNet) biannual meetings for the next five years. The network was created to address issues pertaining to fetal therapy that arose from the NIH workshop held on August 16-17, 2004, "Fetal Treatment: Needs Assessment and Future Directions", which was supported by the National Institutes of Child Health and Human Development (NICHD), the Office of Rare Diseases and the National Heart, Lung, and Blood Institute. It was recommended that a cooperative group of investigators and clinicians be formed to help set a national agenda for research, clinical progress and ethical issues in the field. Further, it was recognized that the development of such a group would be a challenge due to the innovative and entrepreneurial nature of fetal therapy. Participants at the workshop from the Children's Hospital of Philadelphia, University of North Carolina, Vanderbilt University Medical Center and University of San Francisco moved forward during the following year to develop the organizational structure of NAFTNet with the primary mission to create a collaborative clinical research network to study the natural history of fetal disease and develop therapeutic prenatal interventions to improve outcomes. In October of 2005 representatives of 18 major North American fetal therapy units were invited to a meeting in Dallas, TX where the concept, organizational plan and mission of NAFTNet were presented to the group. Twenty centers have now joined agreeing to (1) a peer-review and mentoring process of submission of research protocols (2) participation and support of NAFTNet approved protocols and (3) institutional financial support. The peer-review process is coordinated in the scientific meetings with a free exchange and dissemination of ideas amongst individuals from the participating centers who are authorities in the areas of fetal diagnosis and treatment and ad hoc members representing the specialties of medical ethics and biostatistics. NAFTNet is a 501c3 organization that seeks to achieve appropriate representation of women and racial/ethnic minorities and persons with disabilities. In the past three years 14 research proposals have been submitted, 10 have gained NAFTNet support and are underway, 2 are financially supported by industry and federal funds, 1 is presently under consideration as a collaboration research effort with the EUROFETUS group, a fetal therapy research project funded by the European Commission. PUBLIC HEALTH RELEVANCE: Support is being requested for the biannual North American Fetal Therapy Network (NAFTNet) meetings for the next five years. NAFTNet is a "not for profit" collaborative research organization whose members are recognized authorities in the field of fetal therapy from major clinical research units in the United States and Canada. NAFTNet's primary mission is to provide a cooperative clinical research network to study the natural history of fetal disease and to develop therapeutic prenatal interventions to improve outcomes.

描述（由申请人提供）：要求支持在接下来的五年内承保北美胎儿治疗网络（NAFTNET）双年度会议的成本。该网络的创建目的是解决与2004年8月16日至17日举行的NIH研讨会有关的问题，即“胎儿治疗：需求评估和未来方向”，该机构得到了国家儿童健康与人类发展研究所（NICHD）的支持，罕见疾病办公室，罕见疾病办公室以及国家心脏，肺和血液研究所。建议成立一个合作的研究人员和临床医生，以帮助为该领域的研究，临床进步和道德问题制定国家议程。此外，人们认识到，由于胎儿治疗的创新性和企业家性质，这种群体的发展将是一个挑战。北卡罗来纳州大学儿童医院，范德比尔特大学医学中心和旧金山大学的研讨会的参与者在次年前进，以开发NAFTNET的组织结构，主要使命是创建一个协作临床研究网络，以研究胎儿疾病的自然史和开发治疗培训的培训培训，以改善治疗培训。 2005年10月，邀请18个北美胎儿治疗单位的18个主要代表参加在德克萨斯州达拉斯举行的会议，北美网络的概念，组织计划和使命被提交给该组织。现在有二十个中心加入了同意（1）提交研究方案的同行评审和指导过程（2）参与和支持NAFTNET批准的协议以及（3）机构财务支持。同行评审过程在科学会议上进行了协调，并在参与中心的个人中自由交流和传播思想，这些人是胎儿诊断和治疗领域的当局以及代表医学伦理学和生物统计学专业的临时成员。 NAFTNET是一个501C3组织，旨在实现妇女和种族/族裔少数民族和残疾人的适当代表。在过去的三年中，已提交了14项研究建议，有10项获得了NAFTNET支持并正在进行中，其中2项由行业和联邦资金在财务上得到支持，目前正在考虑1次与Eurofetus Group的合作研究工作，这是由欧洲委员会资助的胎儿治疗研究项目。 公共卫生相关性：未来五年内，将要求提供双年度北美胎儿治疗网络（NAFTNET）会议的支持。 NAFTNET是一个“非盈利”协作研究组织，其成员是美国和加拿大主要临床研究部门的胎儿治疗领域的公认当局。 NAFTNET的主要任务是提供一个合作的临床研究网络，以研究胎儿疾病的自然史并开发治疗性产前干预措施以改善预后。